Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Week in Review: Three New/Expanded Collaborations in Holiday-Shortened Week

publication date: Nov 26, 2022

Deals and Financings

  • Fosun Pharma’s Wanbang subsidiary added animal rights to its development agreement with Vancouver’s Sirona Biochem for a SGLT2 diabetes 2 therapy;
  • Nona Biosciences, a Harbour BioMed subsidiary, will collaborate with Boston-area Dragonfly to discover candidates for bispecific/multi-specific antibodies;
  • Shanghai IASO Bio will collaborate with Umoja Biopharma of Seattle to test the efficacy of Umoja's iCIL off-the-shelf cell therapy platform with IASO’s CAR candidates;

Trials and Approvals

  • Yantai Luye Pharma’s extended-release therapy for schizophrenia and schizoaffective disorders met its endpoints in a US pivotal trial;
  • AnchorDx, a Guangzhou company focused on early detection of cancers, enrolled the first patient in a US trial of its UriFind® bladder cancer assay;
  • Nanjing Triastek was cleared to start US trials of T21, a 3D printed medicine with a targeted release mechanism, for ulcerative colitis.

Stock Symbols: (TSX-V: SBM) (HK: 02142) (HK: 2186)

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here